Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Auxilium Pharmaceuticals,
Trading Rating : - Investor Rating :
More Ratings
Financials ($)
Sales 2014 401 M
EBIT 2014 17,5 M
Net income 2014 -163 M
Debt 2014 479 M
Yield 2014 -
Sales 2015 505 M
EBIT 2015 125 M
Net income 2015 71,5 M
Debt 2015 364 M
Yield 2015 -
PER 2014 -
PER 2015 26,05
EV / Sales 2014 5,81x
EV / Sales 2015 4,38x
Capitalization 1 850 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
02/13 EXCLUSIVE : Drugmaker Endo vying for Salix takeover
02/07 AUXILIUM PHARMACEUTICALS : Endo Acquires Auxilium Pharmaceuticals
02/04 AUXILIUM PHARMACEUTICALS : Endo Completes Acquisition Of Auxilium Pharmaceutical..
02/03 AUXILIUM PHARMACEUTICALS : Endo Buys Auxilium Pharmaceuticals
01/30 AUXILIUM PHARMACEUTICALS : Endo completes $2.6bn acquisition of Auxilium
01/29 AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Terminati..
01/27 AUXILIUM PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders, ..
01/27 AUXILIUM PHARMACEUTICALS : Announces Results from Special Meeting of Stockholder..
More news
Sector news Biopharmaceuticals
05:32a GRIFOLS : to make a major equity investment in Alkahest Download (380.5 Kb)
05:07a ACTAVIS : AstraZeneca completes acquisition of rights to Actavis' branded respir..
05:02a Bavarian Nordic shares leap on $1 billion Bristol-Myers deal
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF